Concepedia

Matt Coffey

MC

Statistics

Publications

59

Citations

4.7K

H-Index

36

Active since

2004

Affiliations

Oncolytics Biotech (Canada)(Current)

Institute of Cancer Research

Mayo Clinic

University of Surrey

St James's University Hospital

Matt Coffey is an author at Oncolytics Biotech (Canada) specializing in oncology, oncolytic virus therapy, and oncolytic viral therapy.

ORCID

Publications per year

2004–2025

59

Publications

59

A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas

Peter Forsyth, Glòria Roldán, David H. George et al. · Molecular Therapy · 2008 · 280 citations · Full text

, , +12

A Phase I Study of Intravenous Oncolytic Reovirus Type 3 Dearing in Patients with Advanced Cancer

Laura Vidal, Hardev Pandha, Timothy A. Yap et al. · Clinical Cancer Research · 2008 · 239 citations

, , +17

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Laura Evgin, Tim Kottke, Jason M. Tonne et al. · Science Translational Medicine · 2022 · 202 citations · Full text

, , +17

Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients

Robert A. Adair, Victoria Roulstone, Karen J. Scott et al. · Science Translational Medicine · 2012 · 193 citations

, , +17

Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity

Fiona Errington‐Mais, Lynette P. Steele, Robin Prestwich et al. · The Journal of Immunology · 2008 · 187 citations · Full text

, , +17

1–5 of 59